CRP and anal carcinoma: Furthermore, elevated plasma CRP levels correlate with reduced progression-free and overall survival across various solid tumors, including glioblastoma multiforme, cervical cancer, anal cancer, and NSCLC, as confirmed by multivariate analyses [212].